|

- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
& g: o9 S# T1 x. n+ l+ O! lwas to close its brain research facility in Basel, Switzerland,
5 @' @0 X: P, @- q4 p; Q4 athe story noted that this move closely followed similar cuts
+ R$ E- _, V" @# qby rival pharmaceutical firms. As a report from the European College
& H9 b% |3 V$ `+ [& d2 u! A9 Kof Neuropsychopharmacology
& L8 m Z1 P3 {( I! I E3 u& [7 x- Zhad warned a few months earlier, the' A2 h+ e8 k6 a' ^
abandonment of research into new psychiatric drugs by AstraZeneca,
9 |( V8 X% q; V1 Y* b7 a6 XGlaxoSmithKline
* H3 F: e5 \3 `4 A9 ?) Fand others meant that “withdrawal of research- t7 d+ r; }# a* Q- F* {
resources is a withdrawal of hope for patients and their families”.
: ?" w) x3 y% Q! R i8 N. x% \2 K: z- @ l6 o) J
: s) W# R% i! z4 u$ g( c- I" E回复有免费下载链接9 }2 X' l& e$ J4 s& e" y
# V" y# Z6 T. ?! g: l; V' r |
-
总评分: 包包 + 20
查看全部评分
|